The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Open accessAbstract
Angiopoietin-2 (Ang2) exhibits broad expression in the remodeling vasculature of human tumors but very limited expression in normal tissues, making it an attractive candidate target for antiangiogenic cancer therapy. To investigate the functional consequences of blocking Ang2 activity, we generated antibodies and peptide-Fc fusion proteins that potently and selectively neutralize the interaction between Ang2 and its receptor, Tie2. Systemic treatment of tumor-bearing mice with these Ang2-blocking agents resulted in tumor stasis, followed by elimination of all measurable tumor in a subset of animals. These effects were accompanied by reduced endothelial cell proliferation, consistent with an antiangiogenic therapeutic mechanism. Anti-Ang2 therapy also prevented VEGF-stimulated neovascularization in a rat corneal model of angiogenesis. These results imply that specific Ang2 inhibition may represent an effective antiangiogenic strategy for treating patients with solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Gerber, H.-P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., & Ferrara, N. (1999) · Nature Medicine · doi:10.1038/9467 · Cited by 2,085
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
Signaling Vascular Morphogenesis and Maintenance
Hanahan, D. (1997) · Science · doi:10.1126/science.277.5322.48 · Cited by 1,190
Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018
Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Gale, N. W., & Yancopoulos, G. D. (1999) · Genes & Development · doi:10.1101/gad.13.9.1055 · Cited by 784
Lobov, I. B., Brooks, P. C., & Lang, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172161899 · Cited by 676 · cited 2×
“It therefore remains unclear exactly what molecular, cellular, and phenotypic roles Ang2 plays in modeling, and enhanced endothelial cell migration (Lobov et al., 2002).”
BackgroundMolecular Cloning and Characterization of Bif-1
Cuddeback, S. M., Yamaguchi, H., Komatsu, K., Miyashita, T., Yamada, M., Wu, C., Singh, S., & Wang, H.-G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101527200 · Cited by 635
Endothelial receptor tyrosine kinases involved in angiogenesis.
Mustonen, T., & Alitalo, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.4.895 · Cited by 526
Stratmann, A., Risau, W., & Plate, K. H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65733-1 · Cited by 485
Bunone, G., Vigneri, P., Mariani, L., Butó, S., Collini, P., Pilotti, S., Pierotti, M. A., & Bongarzone, I. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65515-0 · Cited by 404
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, P., Buxton, J. A., Acheson, A., Radziejewski, C., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8829 · Cited by 371
Visconti, R. P., Richardson, C. D., & Sato, T. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122109599 · Cited by 335
Etoh, T., Inoue, H., Tanaka, S., Barnard, G. F., Kitano, S., & Mori, M. (2001) · PubMed · Cited by 311
Kim, I., Kim, J.-H., Moon, S.-O., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203800 · Cited by 306
Teichert-Kuliszewska, K. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00231-5 · Cited by 291
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
Tanaka, S., Mori, M., Sakamoto, Y., Makuuchi, M., Sugimachi, K., & Wands, J. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4891 · Cited by 256
Lin, P., Polverini, P., Dewhirst, M., Shan, S., Rao, P. S., & Peters, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119740 · Cited by 252
Angiopoietins, growth factors, and vascular morphology in early arthritis.
Fearon, U., Griosios, K., Fraser, A. D., Reece, R., Emery, P., Jones, P. F., & Veale, D. J. (2003) · PubMed · Cited by 245
Zagzag, D., Hooper, A., Friedlander, D. R., Chan, W., Holash, J., Wiegand, S. J., Yancopoulos, G. D., & Grumet, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7162 · Cited by 222
Iwama, A., Hamaguchi, I., Hashiyama, M., Murayama, Y., Yasunaga, K., & Suda, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2045 · Cited by 216
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer.
Ahmad, S. A., Liu, W., Jung, Y. D., Fan, F., Wilson, M., Reinmuth, N., Shaheen, R. M., Bucana, C. D., & Ellis, L. M. (2001) · PubMed · Cited by 208
Angiopoietin‐2 plays an important role in retinal angiogenesis
Hackett, S. F., Wiegand, S., Yancopoulos, G., & Campochiaro, P. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10128 · Cited by 199
Folkman, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9064 · Cited by 198
White, R. R., Shan, S., Rusconi, C. P., Shetty, G., Dewhirst, M. W., Kontos, C. D., & Sullenger, B. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831159100 · Cited by 171
Niitani, H. (1995) · PubMed · Cited by 167
Mochizuki, Y., Nakamura, T., Kanetake, H., & Kanda, S. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.1.175 · Cited by 152
Altered Expression of Angiopoietins and Tie2 Endothelium Receptor in Psoriasis
Kuroda, K., Sapadin, A. N., Shoji, T., Fleischmajer, R., & Lebwohl, M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01316.x · Cited by 148
Siemeister, G., Schirner, M., Weindel, K., Reusch, P., Menrad, A., Marmé, D., & Martiny‐Baron, G. (1999) · PubMed · Cited by 147
Improving the evaluation of new cancer treatments: challenges and opportunities
Rothenberg, M. L., Carbone, D. P., & Johnson, D. H. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1047 · Cited by 145
Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.
Otani, A., Takagi, H., Oh, H., Koyama, S., Matsumura, M., & Honda, Y. (1999) · PubMed · Cited by 134
Angiopoietin-2 Is Implicated in the Regulation of Tumor Angiogenesis
Yu, Q., & Stamenkovic, I. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63998-3 · Cited by 125
Shahrara, S., Volin, M. V., Connors, M. A., Haines, G. K., & Koch, A. E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar407 · Cited by 115
Zangari, M., Anaissie, E. J., Stopeck, A., Morimoto, A. M., Tan, N., Lancet, J. E., Cooper, M. A., Hannah, A. L., Garcia‐Manero, G., Faderl, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0221-3 · Cited by 115
Coxon, A., Bolon, B. N., Estrada, J., Kaufman, S., Scully, S. A., Rattan, A., Duryea, D., Hu, Y., Rex, K. L., Pacheco, E., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10546 · Cited by 89
Self-citationAngiopoietin/Tek Interactions Regulate MMP-9 Expression and Retinal Neovascularization
Das, A., Fanslow, W. C., Cerretti, D. P., Warren, E., Talarico, N. E., & McGuire, P. G. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000097189.79233.d8 · Cited by 83
Systemically Expressed Soluble Tie2 Inhibits Intraocular Neovascularization
Hangai, M., Moon, Y. S., Kitaya, N., Chan, C. K.-C., Wu, D.-Y., Peters, K. G., Ryan, S. J., & Hinton, D. R. (2001) · Human Gene Therapy · doi:10.1089/104303401750270968 · Cited by 75
Hangai, M., Murata, T., Miyawaki, N., Spee, C. K., Lim, J. I., He, S., Hinton, D. R., & Ryan, S. J. (2001) · PubMed · Cited by 73
Expression of angiostatic factors in colorectal cancer.
Yoshida, Y., Oshika, Y., Fukushima, Y., et al. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.6.1221 · Cited by 56
Cited by
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., Shu, H. K., Wen, P. Y., & Olson, J. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20069 · Cited by 1,372
Metadata
- Authors
- Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., Hawkins, N., Rosenfeld, R., Davy, E., Graham, K., Jacobsen, F., Stevenson, S., Ho, J., Chen, Q., Hartmann, T., Michaels, M., Kelley, M., Li, L., Sitney, K., Martin, F., Sun, J.-R., Zhang, N., Lu, J., Estrada, J., Kumar, R., Coxon, A., Kaufman, S., Pretorius, J., Scully, S., Cattley, R., Payton, M., Coats, S., Nguyen, L., Desilva, B., Ndifor, A., Hayward, I., Radinsky, R., Boone, T., & Kendall, R.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 6
- Issue
- 5
- Pages
- 507-516
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1996859043
- Cited by
- 471
- References
- 44
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.